Harrison.ai
Series C in 2025
Harrison.ai is a clinician-led healthcare AI company founded in 2018 and headquartered in Barongarook, Victoria, Australia. The company focuses on using deep learning technology to enhance the success rates of in vitro fertilization (IVF) for patients. By developing customized AI-enabled tools that seamlessly integrate into existing clinical workflows, Harrison.ai aims to empower healthcare providers and improve patient outcomes. Its IVY deep learning model uniquely analyzes comprehensive five-day video feeds from embryo scopes, surpassing the capabilities of traditional AI tools that rely on static images. Harrison.ai combines deep learning expertise with clinical experience to create innovative healthcare solutions, striving to make healthcare products and services more efficient and affordable for medical institutions and patients alike.
Owlstone Medical, established in 2003 and headquartered in Cambridge, UK, specializes in developing and commercializing breathalyzers for clinical diagnostics and precision medicine. The company's core technology, FAIMS, enables the detection of volatile organic compounds in breath, facilitating the discovery of non-invasive biomarkers for various diseases. Owlstone Medical's product portfolio includes breath samplers like ReCIVA and CASPER, as well as analytical tools such as Lonestar and ATLAS, catering to applications like lung cancer, asthma, and gastrointestinal disorders. The company collaborates with market leaders to integrate its technology into next-generation chemical sensing products and has received funding from the UK's Department of Defense to develop a handheld device for enhanced sensitivity and selectivity. Owlstone Medical aims to become a global leader in non-invasive diagnostics, with a focus on early disease detection and a pipeline of medical applications, including colon and lung cancer screening.
Fleet Space Technologies
Series D in 2024
Fleet Space Technologies is an Australian space technology company that operates a fleet of commercial micro-satellites aimed at transforming critical mineral discovery and space exploration. The company has developed innovative solutions, including the world's first 3D-printed all-metal patch antenna for space, which significantly enhances data throughput. Fleet utilizes its satellite constellation to facilitate the exploration of critical minerals globally and provides satellite-enabled systems and seismic array technology to connect Earth, the Moon, and Mars. By offering low-cost satellite-based systems for Industrial Internet of Things applications, Fleet Space Technologies seeks to revolutionize the mineral exploration and defense sectors while advancing space exploration initiatives.
Notpla Limited is a London-based company focused on developing sustainable packaging solutions aimed at reducing plastic waste and environmental impact. Founded in 2014, Notpla creates a range of products derived from seaweed and plants, including biodegradable takeaway food containers, flexible films, and edible sachets. The company's innovative materials are designed to be naturally derived and compostable without the need for specialized facilities, making them accessible for various applications. Notpla aims to contribute to a healthier planet by providing alternatives to conventional packaging that are both functional and environmentally friendly. The company was previously known as Skipping Rocks Lab Limited until it rebranded in July 2019.
ZeroAvia, Inc. is a company focused on developing zero-emission aircraft and hydrogen-electric propulsion systems aimed at transforming short-haul commercial aviation. Established in 2017 and headquartered in Hollister, California, with an additional office in Cranfield, United Kingdom, ZeroAvia is dedicated to eliminating aviation emissions while maintaining operational efficiency. The company's innovative powertrain utilizes a hydrogen fuel-cell system, allowing for retrofitting of existing aircraft and facilitating the adoption of sustainable aviation practices. By emphasizing scalable technologies, ZeroAvia seeks to partner with various stakeholders in the aviation industry to provide cleaner, more efficient flight options, thereby reducing costs and carbon dioxide emissions associated with air travel.
Medal
Venture Round in 2024
Medal is an online platform designed for gamers to create, watch, share, and analyze gaming highlights. The platform allows users to capture key moments from their gameplay using various recording methods, which can then be shared with others. This functionality enables gamers to showcase their skills and enhance their overall gaming experience by easily sharing digital clips and highlights from live streams.
Holoclara
Series A in 2024
Holoclara is an immunotherapy company focused on providing innovative solutions for individuals suffering from autoimmune disorders. The company specializes in delivering nematode-derived molecules known for their therapeutic properties. By identifying and developing these molecules from various worm species, Holoclara aims to create safe, orally available therapeutics that can improve the quality of life for patients. Through its targeted approach, Holoclara seeks to bring relief and promote overall health and well-being for those affected by autoimmune conditions.
Voyage Foods
Series A in 2024
Voyage Foods is a company dedicated to securing the future of beloved foods by addressing health, environmental, and social challenges. Through the use of natural, sustainable, and upcycled ingredients combined with proprietary technology and food science, Voyage creates delicious alternatives that mimic the taste and appearance of traditional foods without compromising on nutrition or sustainability. Their initial product lines include nut-free spreads, cocoa-free chocolate, and bean-free coffee, offering consumers a way to enjoy their favorite treats responsibly.
Fano Labs is an artificial intelligence company based in Shatin, Hong Kong, specializing in speech recognition and natural language processing technologies. Founded in 2015, the company focuses on developing solutions that enable the processing and analysis of various Chinese dialects, particularly Cantonese, as well as other Southeast Asian languages. Fano Labs serves a diverse range of sectors, including customer service, compliance, and operational efficiency for enterprises such as global banks, government agencies, and telecom companies. Their advanced AI technologies enhance management capabilities and service quality by accurately identifying compliance risks and analyzing customer sentiment. By providing valuable business intelligence, Fano Labs helps organizations reduce costs and uncover sales opportunities, ultimately driving revenue growth.
Cauldron Ferm
Series A in 2024
Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities faster and with a lower cost of goods than any traditional production method.
Xampla Ltd is a cleantech company based in Cambridge, United Kingdom, focused on developing and producing plant protein-based materials as sustainable alternatives to conventional plastics. Founded in 2018, Xampla specializes in creating biodegradable and biocompatible products, including microcapsules, beads, films, threads, and various other structures made entirely from pea protein. These materials are designed for diverse commercial applications, spanning sectors such as food, cosmetics, household products, animal feed, packaging, and medical uses. By eliminating synthetic ingredients and reducing reliance on polluting plastics, Xampla aims to provide environmentally friendly solutions that align with the growing demand for sustainable materials in the marketplace.
MioTech
Venture Round in 2024
MioTech Information Technology (Shanghai) Co., Limited is an artificial intelligence platform based in Shanghai, China, with additional offices in Hong Kong. Founded in 2016, the company specializes in developing software solutions for investment managers, enabling them to navigate complex data and enhance client service. MioTech's platform integrates and analyzes diverse data sources to streamline the investment process, offering a data-driven experience. Additionally, the company focuses on sustainability and environmental, social, and corporate governance (ESG) data, providing financial institutions, enterprises, and governments with tools to monitor and manage sustainability metrics in real time. MioTech's innovative approach is supported by notable investors, including Horizons Ventures and ZhenFund.
CellVoyant
Seed Round in 2024
CellVoyant Technologies Limited is an innovative biotechnology company founded in 2021, focused on developing advanced stem cell-based therapies to address chronic diseases. The company employs an AI-first approach, utilizing live cell imaging technology to predict and optimize stem cell differentiation, which allows for the scalable and precise manufacturing of any human cell and tissue. CellVoyant's technology is rooted in pioneering research from the Carazo Salas lab at the University of Bristol, merging expertise in cell biology, computer vision, engineering, and machine learning. Led by Founder and CEO Rafael Carazo, the company aims to translate cutting-edge scientific advancements into real-world applications, addressing critical healthcare challenges. With a commitment to transforming the biotechnology landscape, CellVoyant is positioned to deliver effective, life-changing therapies to patients globally.
Perfect Day
Series E in 2024
Perfect Day, Inc. is a pioneering company based in Emeryville, California, that specializes in producing animal-free dairy products. Founded in 2014, the company creates milk, cheese, yogurt, milk proteins, and ice cream that are nutritionally identical to traditional dairy but are made through a fermentation process using plant-based sugars. This innovative approach allows Perfect Day to deliver products that retain the taste, texture, and nutrition of conventional dairy while eliminating concerns related to food safety, environmental impact, and animal welfare. The company's commitment to sustainability and compassion results in nutrient-dense alternatives that are vegan, free from antibiotics, cholesterol, and lactose, catering to a growing market for healthier and more ethical food options.
Kimia Therapeutics
Series A in 2023
KimiaTherapeutics is a drug discovery business that uses high throughput precision chemistry in conjunction with genome editing and machine learning to uncover druggable sites at crucial nodes of intervention in human disease.
Evolv AI
Venture Round in 2023
Evolv AI is a developer of an artificial intelligence-driven optimization and personalization platform that aims to enhance digital experiences for customers. The company focuses on enabling digital leaders and content creators to engage customers effectively across various digital channels. Its proprietary platform employs a unique methodology to automatically discover and personalize user journeys by adapting to live user behavior. By defining experimentation strategies and generating a continuous stream of innovative ideas, Evolv AI helps organizations progressively improve their digital optimization efforts. This allows businesses to learn from each user interaction and refine their approaches, ultimately driving better customer engagement and conversion rates.
Promise Robotics
Series A in 2023
Promise Robotics is a construction technology company focused on transforming the building industry through industrialized robotics and artificial intelligence. By providing ready-to-deploy robotic systems and Software as a Service (SaaS) production management services, the company aims to facilitate the construction of NetZero-ready timber buildings. Promise Robotics accelerates manufacturing times and mitigates uncertainties in the building process, enabling real estate developers to utilize advanced automation for more efficient and sustainable construction. Through its innovative approach, the company seeks to make affordable building solutions more accessible while promoting environmentally friendly practices in the construction sector.
erthos is a producer of biodegradable packaging materials intended to replace traditional polystyrene and polypropylene inputs.
BioLoomics
Seed Round in 2023
BioLoomics, Inc. is a biotechnology company based in Boulder, Colorado, founded in 2019. It specializes in drug screening services that assess drug action and toxicity by profiling drug effects in live cells using advanced biosensor technology. The company employs directed evolution to develop antibodies with programmable spatial fate in target cells, enhancing the precision of drug discovery. BioLoomics utilizes high-throughput multiplexed profiling to analyze biochemical events in mammalian cells, screening chemical libraries and complex mixtures to identify unique cellular responses. This innovative approach enables clients to improve the success rate and reduce the costs associated with drug development, making significant contributions to the field of synthetic biology and live-cell imaging.
ZeroAvia, Inc. is a company focused on developing zero-emission aircraft and hydrogen-electric propulsion systems aimed at transforming short-haul commercial aviation. Established in 2017 and headquartered in Hollister, California, with an additional office in Cranfield, United Kingdom, ZeroAvia is dedicated to eliminating aviation emissions while maintaining operational efficiency. The company's innovative powertrain utilizes a hydrogen fuel-cell system, allowing for retrofitting of existing aircraft and facilitating the adoption of sustainable aviation practices. By emphasizing scalable technologies, ZeroAvia seeks to partner with various stakeholders in the aviation industry to provide cleaner, more efficient flight options, thereby reducing costs and carbon dioxide emissions associated with air travel.
ALVA is a manufacturer of electric bikes designed for urban commuting, focusing on performance, efficiency, and environmental sustainability. Assembled in Indonesia, ALVA's bikes prioritize motor efficiency and offer impressive torque and top speeds on a single charge. The company's products feature integrated intelligence that enhances rider security, personalization, and control, ensuring a superior riding experience. With a commitment to zero-emissions technology, ALVA aims to facilitate a transition to electric mobility while helping customers reduce riding costs.
Chemify specializes in developing a chemical digitization platform designed to facilitate drug and materials discovery as well as chemical synthesis. The company's innovative approach involves using automated synthetic hardware combined with digital XDL code to convert code into molecules on demand. This system is modular, universal, scalable, and teachable, making it highly versatile for various applications in chemical and material research. Chemify's software includes a unique chemical programming language and natural language recognition capabilities that translate synthetic procedures efficiently. Additionally, the platform features a comprehensive ontology that provides detailed insights into reaction conditions and flags potential issues, offering scientists real-time telemetry of reactions.
Cortical Labs
Seed Round in 2023
Cortical Labs is a pioneering biological computing startup that aims to transform traditional computing by integrating living neurons into chips. Its innovative biOS creates an interactive reality that transmits data through electrical signals, allowing neuronal activity to influence actions within this environment. This dynamic process enables the neurons to adapt in response to perceived outcomes, enhancing their efficiency and effectiveness. By harnessing the unique capabilities of human neurons, which have evolved over billions of years, Cortical Labs' technology offers a new generation of biological computer chips that provide fluid intelligence and energy efficiency. This advancement opens new possibilities for various sectors, including digital spaces, robotics, science, and personal care, facilitating the development of advanced autonomous systems for future applications.
Cauldron Ferm
Seed Round in 2023
Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities faster and with a lower cost of goods than any traditional production method.
Matchday
Seed Round in 2023
Matchday is a gaming platform tailored for football enthusiasts, offering a unique experience where users can collect and trade digital cards within a marketplace. By merging video games, sports, and Web3 technology, Matchday creates an engaging ecosystem for casual football games. The platform empowers users with true ownership of the cards and digital items they acquire, allowing them to build their dream teams and participate in gameplay seamlessly. Through this innovative approach, Matchday caters to the interests of football fans while promoting an interactive and dynamic gaming environment.
doctorly GmbH is a health technology company based in Berlin, Germany, specializing in a cloud-based practice management platform for healthcare professionals. Founded in 2017, the company offers a comprehensive software-as-a-service solution that streamlines various aspects of medical practice management. Its platform enables digital booking, video conferencing, and the management of electronic health records, enhancing efficiency for doctors while improving patient engagement. Additionally, doctorly provides tools for patient health analysis and integrates with other health industry applications, facilitating seamless connections between healthcare providers and patients. By focusing on innovative digital solutions, doctorly aims to drive meaningful improvements in the healthcare sector on an international scale.
Loam Bio is a company focused on manufacturing microbial products designed to reduce atmospheric CO2 levels and enhance soil fertility. Founded in 2016 and based in Orange, Australia, the company is engaged in developing innovative technology that enables the inoculation of crops with symbiotic micro-organisms. This approach aims to improve agricultural sustainability by promoting healthier soils and more efficient carbon management.
Q-CTRL, established in 2017 and based in Pyrmont, Australia, specializes in developing software tools and firmware for the quantum computing sector. Its core solution focuses on reducing and controlling quantum bit errors in quantum hardware devices, a critical challenge in the field. Q-CTRL's quantum control infrastructure software caters to R&D professionals and end-users, accelerating the development of useful quantum computers. The company also develops "software-defined" quantum sensors for applications in defense, intelligence, navigation, and earth observation. Q-CTRL works with global leaders in quantum technology, including universities, national labs, and industry partners, and is an IBM Quantum Startup network member. It has received numerous awards and recognitions, including being named a World Economic Forum Global Innovator and featured in prominent international publications.
Asimov, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on designing and developing genetically engineered therapeutics. Founded in 2017, the company specializes in creating tools for programming living cells, utilizing a multidisciplinary approach that integrates mammalian synthetic biology, computer-aided design, and machine learning. Asimov's platform includes the development of genetic circuits for molecular manufacturing and therapeutic applications, alongside the manufacture of protein biologics, viral vectors, and cell and gene therapies. By combining synthetic biology with biophysical simulations and machine learning algorithms, Asimov aims to optimize the design and production of advanced biologics and gene therapies, thereby contributing to innovations in healthcare.
Syzygy Plasmonics
Series C in 2022
Syzygy Plasmonics, Inc. is a Houston-based company that specializes in the design, development, and manufacturing of photocatalytic reactor systems for industrial chemical reactions. Founded in 2017, the company focuses on creating reactors that facilitate the generation of fuel cell quality hydrogen from ammonia, specifically for small-to-medium-scale applications. These advanced reactors operate at significantly lower temperatures than traditional chemical reactors, allowing for reduced maintenance costs and the ability to quickly start or stop production. By utilizing light as an energy source, Syzygy Plasmonics enables the integration of renewable electricity into chemical manufacturing, contributing to the decarbonization of various industries and supporting the on-site production of ultra-low-cost hydrogen gas for fuel cell vehicles.
Detect they build tools that empower people to understand their health.
Juvena Therapeutics
Series A in 2022
Juvena Therapeutics, Inc. is a biopharmaceutical company based in San Mateo, California, founded in 2017. The company focuses on developing protein-based therapeutics aimed at promoting tissue rejuvenation, primarily targeting age-related conditions such as sarcopenia, wound healing, and neural regeneration. Juvena Therapeutics utilizes a drug discovery platform that screens for restored cellular functions to create innovative therapeutics that facilitate tissue regeneration and repair. By decoding secreted proteins, the company aims to address various chronic and rare diseases, ultimately enhancing the quality of life for elderly patients.
Nourish Ingredients
Series A in 2022
Nourish Ingredients is a food technology company based in Canberra, Australia, that specializes in creating fat molecules identical to those found in animals, using innovative precision fermentation techniques. Founded in 2019, the company developed proprietary strains that can mass-produce these fat molecules, allowing for the production of plant-based foods that closely mimic the flavor, aroma, and cooking experience associated with animal fats. By providing alternatives to traditional animal-based ingredients, Nourish Ingredients aims to enhance the quality of plant-based products, making them more appealing to consumers seeking authentic taste without the environmental and ethical concerns related to animal agriculture.
Kneron, established in 2015, specializes in designing and developing integrated software and hardware solutions for edge artificial intelligence (AI). The company, headquartered in San Diego with offices in China, offers products such as neural processing unit (NPU) intellectual property, AI System-on-Chips, and visual recognition software development kits. These solutions enable AI functionality on devices at the edge, serving applications like smart homes, smart surveillance, smartphones, robots, drones, and IoT devices. Kneron's offerings facilitate real-time recognition, inference, and analysis without cloud connection, allowing for swift AI application implementation.
SaNOtize is a biotechnology company founded in 2017 and headquartered in Vancouver, British Columbia. It specializes in developing a Nitric Oxide Releasing Solution platform technology aimed at treating and preventing upper respiratory and dermal infections. The company's innovative approach offers non-antibiotic antimicrobial solutions effective against a wide range of infectious pathogens, including drug-resistant microbes. SaNOtize's target indications encompass various conditions such as strep throat, athlete's foot, infected wounds, diabetic foot ulcers, sinusitis, and cold and flu, among others. By providing healthcare professionals with advanced tools to combat bacteria, viruses, and fungi, SaNOtize aims to enhance treatment options in the medical field.
Carmot Therapeutics
Series D in 2022
Carmot Therapeutics, Inc. is a clinical-stage biotechnology company based in Berkeley, California, with an additional office in San Francisco. Founded in 2008, it focuses on discovering and developing innovative therapies for patients with metabolic diseases, including obesity and diabetes. Utilizing its proprietary Chemotype Evolution technology, Carmot Therapeutics aims to address the underlying causes of these conditions and accelerate the discovery of effective treatments. The company’s portfolio includes several clinical-stage drug candidates, such as CT-388 and CT-996, which are designed as GLP-1 receptor agonists for the treatment of obesity and type 2 diabetes, and CT-868, intended for type 1 diabetes patients who are overweight or obese. Through these efforts, Carmot Therapeutics seeks to create life-changing therapeutics that improve the health outcomes of individuals affected by metabolic diseases.
Normative.io
Series B in 2022
Normative.io is a software company that specializes in assessing the social and environmental impact of companies by analyzing their purchases. Utilizing artificial intelligence and the world's largest sustainability research database, Normative's platform provides an emission accounting engine that helps organizations calculate their total carbon dioxide emissions. The software also offers visual analytics and generates comprehensive sustainability reports, processing both internal and external data to automate carbon reporting. By making the social and environmental costs of purchases transparent, Normative aims to facilitate progress toward achieving the Sustainable Development Goals and assist businesses in reducing their environmental footprint.
Spiderwort
Series A in 2022
Spiderwort is an innovative company based in Ottawa, Ontario, founded in 2015, focused on developing biomaterials for regenerative medicine. The company specializes in creating cellulose-based biomaterials that serve as living scaffolds, which can be utilized for various medical applications, including spinal cord injury repair and soft tissue regeneration. Spiderwort's products encompass a range of biological and synthetic polymers available in multiple forms, such as powders, gels, membranes, and pastes. Currently in the pre-clinical stage, their novel biomaterials have shown promising results in terms of biocompatibility and the ability to induce angiogenesis, which is the generation of blood vessels within the scaffold. This approach aims to advance the repair and regeneration of tissues within the human body, providing new solutions for challenging medical conditions.
Wefox is a technology company specializing in the insurance sector. It operates a digital platform that connects insurance providers, brokers, businesses, and customers, facilitating access to various insurance solutions. The company focuses on indirect sales, partnering with intermediaries to expand its market reach. Wefox's platform offers services such as policy management, claims settlement, and quotation generation for a range of insurance types, including health, liability, and disability.
Keel.Labs
Series A in 2022
Keel Labs is a biomaterials company that focuses on developing ocean-based materials derived from renewable resources, particularly seaweed. The company aims to address the ecological damage caused by the fashion industry by creating durable and rapidly degradable yarns from kelp. Through its innovative platform, Keel Labs integrates scientific design and waste management into textile production, offering an alternative to conventional textiles for the footwear and apparel industries. This approach not only provides a functional resource but also emphasizes environmental sustainability, allowing for a more responsible and accessible option in material sourcing.
Atomo Coffee
Series A in 2022
Atomo Coffee Inc, founded in 2019 and based in Seattle, Washington, specializes in the development of molecular coffee. The company has innovatively reverse-engineered the coffee bean to produce a smooth cup of coffee using naturally derived ingredients. This approach aims to offer a more sustainable alternative to traditional coffee production methods, addressing environmental concerns associated with coffee cultivation. By focusing on sustainability and quality, Atomo Coffee is positioned to disrupt the conventional coffee market with its unique product offerings.
Manifold Bio
Series A in 2022
Manifold Biotechnologies, Inc. is a biotechnology company that specializes in developing platforms for the pharmacological measurement of various therapeutic protein variants. By integrating DNA technologies with machine learning, the company aims to create protein drugs that address challenging diseases. Manifold Bio's innovative approach includes a protein barcoding platform designed to enable multiplexed quantitation of protein therapeutics, thereby generating extensive data that enhances the drug development process. Founded in 2019 and located in Allston, Massachusetts, the company is focused on advancing measurement-driven design in the field of protein therapeutics.
Getquin is a financial technology company that offers a comprehensive platform for investors to manage and track their entire net worth in one location. The platform is designed to facilitate the creation and management of exchange-traded fund portfolios, allowing users to analyze their assets and make informed investment decisions. By providing tools to monitor investments continuously, Getquin fosters a community of like-minded investors, enhancing the decision-making process through shared insights and information. This integrated approach aims to empower individuals to take control of their financial futures.
Voyage Foods
Series A in 2022
Voyage Foods is a company dedicated to securing the future of beloved foods by addressing health, environmental, and social challenges. Through the use of natural, sustainable, and upcycled ingredients combined with proprietary technology and food science, Voyage creates delicious alternatives that mimic the taste and appearance of traditional foods without compromising on nutrition or sustainability. Their initial product lines include nut-free spreads, cocoa-free chocolate, and bean-free coffee, offering consumers a way to enjoy their favorite treats responsibly.
Kelonia Therapeutics
Series A in 2022
Kelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform. The company's cutting-edge in vivo gene delivery technology is simple and elegant, relying on a few potent lentiviral vector-like particles to precisely and efficiently deliver genetic cargo to the desired target tissue, and only that tissue, every time. To deliver genetic cargo only to the desired tissue, the lentiviral vector gene delivery platform employs a simple and elegant solution based on decades of research, development, and technical experience. Kelonia's mission is to develop a new wave of accessible genetic medicines that will transform the lives of patients suffering from a broad range of conditions.
Ansa Biotechnologies
Series A in 2022
Ansa Biotechnologies, Inc. is a biotechnology company based in Berkeley, California, focused on developing innovative DNA synthesis technology utilizing enzymes. Founded in 2018, the company aims to transform the traditional methods of DNA production, which have remained largely unchanged for decades. Ansa's enzymatic approach promises to be faster, more accurate, and environmentally friendly compared to conventional chemical methods. This advanced technology facilitates the synthesis of gene-length oligonucleotides, enabling medical researchers to create synthetic genes efficiently. Ansa Biotechnologies' offerings are designed to support a wide range of applications in biological research, diagnostics, therapeutics, and biomanufacturing, ultimately accelerating innovation in the field of biotechnology.
Micro Connect
Series B in 2022
Micro Connect is a financial market platform that specializes in connecting global capital with China's micro and small businesses. The company focuses on enhancing liquidity in small business investments by providing professional investors with a new alternative to traditional impact investing. Micro Connect introduces Daily Revenue Obligations (DROs), an innovative asset class that allows investors to gain direct and diversified exposure to the daily cash flows of numerous retail establishments within China's dynamic consumer market. By facilitating access to capital for business owners, Micro Connect aims to create a more affordable financial ecosystem, while also offering structured product solutions and operating a licensed exchange.
Concerto Biosciences
Venture Round in 2022
Concerto Biosciences is focused on rebuilding microbial communities to enhance human health and environmental sustainability. The company has developed a pioneering ultra-high-throughput platform that allows for the experimental measurement of millions of microbial interactions, enabling the mapping of complex inter-species interaction networks. This innovative approach has led to the discovery of "ensembles," which are specific combinations of microbes that synergistically promote the healing of damaged microbial communities. By leveraging these microbial ensembles, Concerto aims to address critical challenges in various sectors, including medicine and agriculture, ultimately transforming the way humanity interacts with microbes and improving outcomes in health and food production.
Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in single-cell analysis technology. Founded in 2015, the company has developed an AI-powered imaging and microfluidics platform that offers a non-invasive method for genetic testing with diagnostic-level accuracy. This platform enables researchers to classify and isolate viable cells based on their morphological characteristics, thus facilitating improved diagnosis and treatment of diseases. By providing detailed genetic health information through ordinary blood samples, Deepcell aims to enhance translational research, diagnostic testing, and therapeutic applications, ultimately reducing the need for invasive procedures in medical diagnostics.
Soul Machines
Series B in 2022
Soul Machines Limited, founded in 2016 and headquartered in Auckland, New Zealand, specializes in the development of emotionally responsive avatars that enhance user experiences across various artificial intelligence platforms. The company utilizes its innovative Biological AI technology and patented Digital Brain™ to create engaging and empathetic AI assistants, which can be customized for applications in customer care, sales, marketing, education, and more. Through its Digital DNA Studio, Soul Machines enables users to design personalized digital personas that facilitate deep interactivity and meaningful brand engagement. With additional offices in major cities such as San Francisco, New York, London, Tokyo, and Melbourne, Soul Machines is dedicated to pioneering the humanization of AI, offering ethical and responsive solutions that foster collaboration between humans and machines.
H2Pro Ltd., established in 2019 and headquartered in Caesarea, Israel, specializes in developing innovative water-splitting technology for green hydrogen production. The company's proprietary E-TAC (Electrochemical–Thermally-Activated Chemical) process decouples the hydrogen and oxygen evolution reactions, enabling efficient, affordable, safe, and sustainable hydrogen fuel generation. H2Pro aims to facilitate widespread adoption of sustainable hydrogen fuel through its novel technology.
Fertilis
Seed Round in 2022
Fertilis is a biotechnology company specializing in advanced infertility treatments. It develops innovative IVF technologies aimed at reducing stress and enhancing success rates for both patients and clinicians. The company's core product is an automated cell culture system that standardizes and optimizes the IVF process using micromedical devices, including a patented micro-3D printed pod designed to provide an optimal growth environment for embryos.
MeMed
Venture Round in 2022
MeMed Diagnostics Ltd. is a personalized diagnostics company founded in 2009 and headquartered in Tirat Carmel, Israel. The company specializes in developing innovative diagnostic solutions to enhance patient care and reduce healthcare costs by providing rapid and actionable insights for infectious diseases. Its flagship product, MeMed BV, is a test designed to distinguish between bacterial and viral infections, while the ImmunoDx platform utilizes proprietary biomarkers and algorithms to analyze patients' immune responses, helping physicians make informed antibiotic treatment decisions. MeMed's technologies aim to mitigate the misuse of antibiotics, which is a significant issue globally, leading to ineffective treatments and the emergence of resistant bacterial strains. By addressing the diagnostic gaps in infectious disease management, MeMed seeks to improve clinical outcomes and promote the responsible use of antibiotics.
Eikon Therapeutics
Series B in 2022
Eikon Therapeutics, Inc. is a biopharmaceutical company based in Hayward, California, focused on developing innovative treatments for chronic and life-threatening diseases. Established in 2019, the company employs advanced super-resolution microscopy and live-cell imaging techniques to discover drugs targeting previously intractable proteins. By directly measuring the interactions of chemical compounds with individual proteins within a live cellular environment, Eikon Therapeutics enhances the understanding of biological processes and supports the development of targeted therapies. The integration of biology, engineering, and chemistry in its proprietary platforms allows Eikon Therapeutics to streamline the drug discovery process, advance clinical programs, and expand its pipeline of potential medications.
Kopi Kenangan
Series C in 2021
Kopi Kenangan is a grab-and-go coffee chain based in Indonesia that aims to meet the growing demand for fresh coffee beverages in a country with low per capita coffee consumption, despite being one of the world's largest coffee exporters. The company focuses on providing authentic coffee blends sourced from various regions in Indonesia, complemented by organic palm sugar to enhance flavor. Its business model includes order-and-pickup and delivery options, allowing customers convenient access to a diverse range of freshly prepared coffee and other beverages at affordable prices. Through this approach, Kopi Kenangan seeks to cater to the evolving preferences of coffee consumers in the region.
ZeroAvia, Inc. is a company focused on developing zero-emission aircraft and hydrogen-electric propulsion systems aimed at transforming short-haul commercial aviation. Established in 2017 and headquartered in Hollister, California, with an additional office in Cranfield, United Kingdom, ZeroAvia is dedicated to eliminating aviation emissions while maintaining operational efficiency. The company's innovative powertrain utilizes a hydrogen fuel-cell system, allowing for retrofitting of existing aircraft and facilitating the adoption of sustainable aviation practices. By emphasizing scalable technologies, ZeroAvia seeks to partner with various stakeholders in the aviation industry to provide cleaner, more efficient flight options, thereby reducing costs and carbon dioxide emissions associated with air travel.
Wonder Dynamics
Series A in 2021
Wonder Dynamics is a media-tech startup based in Los Angeles, California, co-founded by Tye Sheridan and Nikola Todorovic. The company specializes in developing AI technology to enhance storytelling, particularly focusing on creating an AI production tool that enables independent filmmakers to achieve high-quality visual effects typically associated with big-budget productions at a significantly lower cost. Their technology also allows viewers to engage in AI-powered conversations with characters in TV shows or movies, thereby enhancing the viewing experience.
Notpla Limited is a London-based company focused on developing sustainable packaging solutions aimed at reducing plastic waste and environmental impact. Founded in 2014, Notpla creates a range of products derived from seaweed and plants, including biodegradable takeaway food containers, flexible films, and edible sachets. The company's innovative materials are designed to be naturally derived and compostable without the need for specialized facilities, making them accessible for various applications. Notpla aims to contribute to a healthier planet by providing alternatives to conventional packaging that are both functional and environmentally friendly. The company was previously known as Skipping Rocks Lab Limited until it rebranded in July 2019.
Harrison.ai
Series B in 2021
Harrison.ai is a clinician-led healthcare AI company founded in 2018 and headquartered in Barongarook, Victoria, Australia. The company focuses on using deep learning technology to enhance the success rates of in vitro fertilization (IVF) for patients. By developing customized AI-enabled tools that seamlessly integrate into existing clinical workflows, Harrison.ai aims to empower healthcare providers and improve patient outcomes. Its IVY deep learning model uniquely analyzes comprehensive five-day video feeds from embryo scopes, surpassing the capabilities of traditional AI tools that rely on static images. Harrison.ai combines deep learning expertise with clinical experience to create innovative healthcare solutions, striving to make healthcare products and services more efficient and affordable for medical institutions and patients alike.
Q-CTRL, established in 2017 and based in Pyrmont, Australia, specializes in developing software tools and firmware for the quantum computing sector. Its core solution focuses on reducing and controlling quantum bit errors in quantum hardware devices, a critical challenge in the field. Q-CTRL's quantum control infrastructure software caters to R&D professionals and end-users, accelerating the development of useful quantum computers. The company also develops "software-defined" quantum sensors for applications in defense, intelligence, navigation, and earth observation. Q-CTRL works with global leaders in quantum technology, including universities, national labs, and industry partners, and is an IBM Quantum Startup network member. It has received numerous awards and recognitions, including being named a World Economic Forum Global Innovator and featured in prominent international publications.
Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.
Fleet Space Technologies
Series B in 2021
Fleet Space Technologies is an Australian space technology company that operates a fleet of commercial micro-satellites aimed at transforming critical mineral discovery and space exploration. The company has developed innovative solutions, including the world's first 3D-printed all-metal patch antenna for space, which significantly enhances data throughput. Fleet utilizes its satellite constellation to facilitate the exploration of critical minerals globally and provides satellite-enabled systems and seismic array technology to connect Earth, the Moon, and Mars. By offering low-cost satellite-based systems for Industrial Internet of Things applications, Fleet Space Technologies seeks to revolutionize the mineral exploration and defense sectors while advancing space exploration initiatives.
Seasoned.co
Series A in 2021
Seasoned, LLC operates a professional networking platform specifically designed for foodservice industry professionals, including cooks, dishwashers, servers, and gig workers. Based in San Francisco with an additional office in Austin, the company connects workers with job opportunities and fosters career development. Seasoned offers resources such as video courses and articles to help individuals enhance their skills and succeed in their careers. The platform also facilitates networking among foodservice workers, allowing them to share tools, build teams, and improve retention and customer experiences. Founded by a team with extensive experience in the restaurant sector, Seasoned addresses the unique challenges faced by foodservice professionals while promoting growth and collaboration within the industry.
Loam Bio is a company focused on manufacturing microbial products designed to reduce atmospheric CO2 levels and enhance soil fertility. Founded in 2016 and based in Orange, Australia, the company is engaged in developing innovative technology that enables the inoculation of crops with symbiotic micro-organisms. This approach aims to improve agricultural sustainability by promoting healthier soils and more efficient carbon management.
Ansa Biotechnologies
Funding Round in 2021
Ansa Biotechnologies, Inc. is a biotechnology company based in Berkeley, California, focused on developing innovative DNA synthesis technology utilizing enzymes. Founded in 2018, the company aims to transform the traditional methods of DNA production, which have remained largely unchanged for decades. Ansa's enzymatic approach promises to be faster, more accurate, and environmentally friendly compared to conventional chemical methods. This advanced technology facilitates the synthesis of gene-length oligonucleotides, enabling medical researchers to create synthetic genes efficiently. Ansa Biotechnologies' offerings are designed to support a wide range of applications in biological research, diagnostics, therapeutics, and biomanufacturing, ultimately accelerating innovation in the field of biotechnology.
Ajaib is a financial technology company based in Jakarta, Indonesia, that operates an online wealth management platform aimed at democratizing access to investment opportunities. Founded in 2019, Ajaib provides a user-friendly application that allows Indonesians to buy and sell a variety of financial instruments, including stocks, exchange-traded funds (ETFs), and mutual funds. The platform is designed to be accessible to individuals from all walks of life, offering low minimum investment requirements and no account fees. Ajaib's mission is to facilitate safe, trusted, and affordable investment options, helping users save and grow their money with reduced risk.
Perfect Day
Series D in 2021
Perfect Day, Inc. is a pioneering company based in Emeryville, California, that specializes in producing animal-free dairy products. Founded in 2014, the company creates milk, cheese, yogurt, milk proteins, and ice cream that are nutritionally identical to traditional dairy but are made through a fermentation process using plant-based sugars. This innovative approach allows Perfect Day to deliver products that retain the taste, texture, and nutrition of conventional dairy while eliminating concerns related to food safety, environmental impact, and animal welfare. The company's commitment to sustainability and compassion results in nutrient-dense alternatives that are vegan, free from antibiotics, cholesterol, and lactose, catering to a growing market for healthier and more ethical food options.
Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.
Prospection
Series B in 2021
Prospection Pty Ltd, established in 2009, is a Sydney-based software company specializing in healthcare data analytics. It develops SaaS platforms that transform complex healthcare data into actionable insights. Key products include PharmDash, which analyzes patient drug usage and treatment progression, and PharmMap, which integrates commercial and operational data using geospatial mapping. Prospection serves pharmaceutical companies, research institutions, and hospitals worldwide, aiding them in optimizing drug performance and enhancing patient outcomes.
Owlstone Medical, established in 2003 and headquartered in Cambridge, UK, specializes in developing and commercializing breathalyzers for clinical diagnostics and precision medicine. The company's core technology, FAIMS, enables the detection of volatile organic compounds in breath, facilitating the discovery of non-invasive biomarkers for various diseases. Owlstone Medical's product portfolio includes breath samplers like ReCIVA and CASPER, as well as analytical tools such as Lonestar and ATLAS, catering to applications like lung cancer, asthma, and gastrointestinal disorders. The company collaborates with market leaders to integrate its technology into next-generation chemical sensing products and has received funding from the UK's Department of Defense to develop a handheld device for enhanced sensitivity and selectivity. Owlstone Medical aims to become a global leader in non-invasive diagnostics, with a focus on early disease detection and a pipeline of medical applications, including colon and lung cancer screening.
Alpaca is a developer-focused financial technology platform that provides a modern brokerage infrastructure for accessing financial markets. The company offers services that include stock and cryptocurrency investing, real-time market data, and comprehensive brokerage capabilities through user-friendly application programming interfaces (APIs). This enables developers to create trading applications and integrate investment functionalities into various products. Alpaca supports a diverse range of businesses and applications globally, catering to tens of thousands of developers who utilize its platform to enhance their financial offerings. The company has attracted significant funding from leading investors in the sector, positioning itself as a prominent player in the embedded finance landscape.
V2food is a plant-based meat startup founded in 2019 by Nick Hazell and located in Sydney, New South Wales, Australia. The company specializes in producing legume-based meat alternatives that provide a nutritious and flavorful option for individuals who enjoy the taste of meat but prefer not to consume animal products. V2food's offerings are designed to be sustainable and eco-friendly, utilizing natural ingredients that deliver essential protein, energy, fiber, and specific amino acids. By focusing on reducing greenhouse gas emissions, land degradation, and biodiversity loss, V2food aims to foster a positive relationship with food while contributing to a more sustainable food system.
ZeroAvia
Venture Round in 2021
ZeroAvia, Inc. is a company focused on developing zero-emission aircraft and hydrogen-electric propulsion systems aimed at transforming short-haul commercial aviation. Established in 2017 and headquartered in Hollister, California, with an additional office in Cranfield, United Kingdom, ZeroAvia is dedicated to eliminating aviation emissions while maintaining operational efficiency. The company's innovative powertrain utilizes a hydrogen fuel-cell system, allowing for retrofitting of existing aircraft and facilitating the adoption of sustainable aviation practices. By emphasizing scalable technologies, ZeroAvia seeks to partner with various stakeholders in the aviation industry to provide cleaner, more efficient flight options, thereby reducing costs and carbon dioxide emissions associated with air travel.
Bad Robot Games
Series B in 2021
Bad Robot Games, founded by filmmaker J.J. Abrams, focuses on storytelling and world-building through the medium of games. The company leverages the expertise of industry veterans from both the gaming and entertainment sectors, creating immersive experiences that blend interactive gameplay with cinematic narratives. Bad Robot Games aims to unite diverse artistic perspectives to develop expansive worlds that engage audiences across various platforms, including gaming, animation, and motion films. With a commitment to innovation and creativity, the company aspires to deliver experiences that are enjoyable to both play and watch. Based in Santa Monica, Bad Robot Games is part of the broader Bad Robot brand, known for its successful television and film projects.
Modern Meadow
Series C in 2021
Modern Meadow, LLC is a biofabrication company based in Brooklyn, New York, that specializes in creating animal-free leather derived from living cells. Founded in 2011, the company operates at the intersection of material science and biology, utilizing its proprietary Bio-Alloy and Bio-Farm technologies to engineer sustainable materials. These innovations leverage tuned proteins to replace petrochemical and animal-derived inputs, ensuring high performance without compromising on quality. Modern Meadow's products are designed for immediate scalable adoption across various industries, including materials and beauty, and emphasize traceability from lab to brand. By focusing on fermentation-based bio-collagen and other protein applications, the company promotes environmental sustainability by significantly reducing greenhouse gas emissions, while maintaining the biological functions of materials for optimal quality and appearance.
Syzygy Plasmonics
Series B in 2021
Syzygy Plasmonics, Inc. is a Houston-based company that specializes in the design, development, and manufacturing of photocatalytic reactor systems for industrial chemical reactions. Founded in 2017, the company focuses on creating reactors that facilitate the generation of fuel cell quality hydrogen from ammonia, specifically for small-to-medium-scale applications. These advanced reactors operate at significantly lower temperatures than traditional chemical reactors, allowing for reduced maintenance costs and the ability to quickly start or stop production. By utilizing light as an energy source, Syzygy Plasmonics enables the integration of renewable electricity into chemical manufacturing, contributing to the decarbonization of various industries and supporting the on-site production of ultra-low-cost hydrogen gas for fuel cell vehicles.
ZeroAvia, Inc. is a company focused on developing zero-emission aircraft and hydrogen-electric propulsion systems aimed at transforming short-haul commercial aviation. Established in 2017 and headquartered in Hollister, California, with an additional office in Cranfield, United Kingdom, ZeroAvia is dedicated to eliminating aviation emissions while maintaining operational efficiency. The company's innovative powertrain utilizes a hydrogen fuel-cell system, allowing for retrofitting of existing aircraft and facilitating the adoption of sustainable aviation practices. By emphasizing scalable technologies, ZeroAvia seeks to partner with various stakeholders in the aviation industry to provide cleaner, more efficient flight options, thereby reducing costs and carbon dioxide emissions associated with air travel.
Ajaib is a financial technology company based in Jakarta, Indonesia, that operates an online wealth management platform aimed at democratizing access to investment opportunities. Founded in 2019, Ajaib provides a user-friendly application that allows Indonesians to buy and sell a variety of financial instruments, including stocks, exchange-traded funds (ETFs), and mutual funds. The platform is designed to be accessible to individuals from all walks of life, offering low minimum investment requirements and no account fees. Ajaib's mission is to facilitate safe, trusted, and affordable investment options, helping users save and grow their money with reduced risk.
Nourish Ingredients
Seed Round in 2021
Nourish Ingredients is a food technology company based in Canberra, Australia, that specializes in creating fat molecules identical to those found in animals, using innovative precision fermentation techniques. Founded in 2019, the company developed proprietary strains that can mass-produce these fat molecules, allowing for the production of plant-based foods that closely mimic the flavor, aroma, and cooking experience associated with animal fats. By providing alternatives to traditional animal-based ingredients, Nourish Ingredients aims to enhance the quality of plant-based products, making them more appealing to consumers seeking authentic taste without the environmental and ethical concerns related to animal agriculture.
Keel.Labs
Venture Round in 2021
Keel Labs is a biomaterials company that focuses on developing ocean-based materials derived from renewable resources, particularly seaweed. The company aims to address the ecological damage caused by the fashion industry by creating durable and rapidly degradable yarns from kelp. Through its innovative platform, Keel Labs integrates scientific design and waste management into textile production, offering an alternative to conventional textiles for the footwear and apparel industries. This approach not only provides a functional resource but also emphasizes environmental sustainability, allowing for a more responsible and accessible option in material sourcing.
Voyage Foods
Seed Round in 2021
Voyage Foods is a company dedicated to securing the future of beloved foods by addressing health, environmental, and social challenges. Through the use of natural, sustainable, and upcycled ingredients combined with proprietary technology and food science, Voyage creates delicious alternatives that mimic the taste and appearance of traditional foods without compromising on nutrition or sustainability. Their initial product lines include nut-free spreads, cocoa-free chocolate, and bean-free coffee, offering consumers a way to enjoy their favorite treats responsibly.
ALE is a pioneering company founded in 2011 that specializes in creating innovative space entertainment experiences, including the world's first man-made meteor showers. By utilizing microsatellites to release particles that create atmospheric phenomena, ALE aims to merge meteor science with entertainment, stimulating public curiosity about space and science. The company operates with two primary goals: to entertain and inspire people while collecting valuable data from the mesosphere to enhance understanding of atmospheric phenomena and contribute to climate change research. ALE fosters a collaborative community of scientists, decision-makers, and the general public, promoting the exploration of the universe and encouraging a sustainable future on Earth. Through its unique approach, ALE connects scientific knowledge with societal interest, making the cosmos an engaging cultural sphere.
Otter.ai, Inc. is a technology company specializing in artificial intelligence-driven applications designed for capturing and managing voice conversations. Founded in 2016 and headquartered in Los Altos, California, Otter.ai offers a collaborative note-taking platform that allows users to generate, store, and share notes from meetings, interviews, and lectures in real-time. Its flagship product, Otter, utilizes advanced speech recognition technology to provide features such as speaker separation, speaker identification, and keyword extraction, making it easier for individuals, teams, and educational institutions to access and organize important information. The application is widely used by business professionals, journalists, and students to enhance productivity and collaboration by transforming voice conversations into searchable and actionable notes.
Kuato
Venture Round in 2021
Kuato Studios is an educational games developer based in London that focuses on enhancing children's learning through engaging video games. The company aims to capture the excitement of learning by blending high production values with innovative educational methodologies. Kuato's team consists of professionals from renowned gaming studios, AI experts, and award-winning educators, fostering a collaborative environment that balances development and educational objectives. Their adaptive learning platform, KAI, personalizes educational experiences, ensuring that each user is motivated and engaged. By prioritizing narrative learning play, Kuato enables young learners to explore and share their stories in a playful manner, setting a new standard for educational games.
Ajaib is a financial technology company based in Jakarta, Indonesia, that operates an online wealth management platform aimed at democratizing access to investment opportunities. Founded in 2019, Ajaib provides a user-friendly application that allows Indonesians to buy and sell a variety of financial instruments, including stocks, exchange-traded funds (ETFs), and mutual funds. The platform is designed to be accessible to individuals from all walks of life, offering low minimum investment requirements and no account fees. Ajaib's mission is to facilitate safe, trusted, and affordable investment options, helping users save and grow their money with reduced risk.
Xampla Ltd is a cleantech company based in Cambridge, United Kingdom, focused on developing and producing plant protein-based materials as sustainable alternatives to conventional plastics. Founded in 2018, Xampla specializes in creating biodegradable and biocompatible products, including microcapsules, beads, films, threads, and various other structures made entirely from pea protein. These materials are designed for diverse commercial applications, spanning sectors such as food, cosmetics, household products, animal feed, packaging, and medical uses. By eliminating synthetic ingredients and reducing reliance on polluting plastics, Xampla aims to provide environmentally friendly solutions that align with the growing demand for sustainable materials in the marketplace.
ZeroAvia, Inc. is a company focused on developing zero-emission aircraft and hydrogen-electric propulsion systems aimed at transforming short-haul commercial aviation. Established in 2017 and headquartered in Hollister, California, with an additional office in Cranfield, United Kingdom, ZeroAvia is dedicated to eliminating aviation emissions while maintaining operational efficiency. The company's innovative powertrain utilizes a hydrogen fuel-cell system, allowing for retrofitting of existing aircraft and facilitating the adoption of sustainable aviation practices. By emphasizing scalable technologies, ZeroAvia seeks to partner with various stakeholders in the aviation industry to provide cleaner, more efficient flight options, thereby reducing costs and carbon dioxide emissions associated with air travel.
Refeyn Ltd, founded in 2018 and based in Oxford, United Kingdom, specializes in mass photometry, a technology that enables the analysis of biomolecules. The company's flagship product, Refeyn One, utilizes single molecule light scattering to detect, image, and accurately determine the mass of biomolecules in solution. Refeyn's innovative optical technology allows researchers to measure the mass of individual molecules across various biologically relevant concentrations without the need for labels, providing both quality-control instruments and advanced research tools. This capability enhances the understanding of biomolecular behavior in their native states, facilitating significant advancements in the field of biochemistry and molecular biology.
V2food is a plant-based meat startup founded in 2019 by Nick Hazell and located in Sydney, New South Wales, Australia. The company specializes in producing legume-based meat alternatives that provide a nutritious and flavorful option for individuals who enjoy the taste of meat but prefer not to consume animal products. V2food's offerings are designed to be sustainable and eco-friendly, utilizing natural ingredients that deliver essential protein, energy, fiber, and specific amino acids. By focusing on reducing greenhouse gas emissions, land degradation, and biodiversity loss, V2food aims to foster a positive relationship with food while contributing to a more sustainable food system.
Federation Bio
Series A in 2020
Federation Bio Inc., established in 2018 and headquartered in South San Francisco, California, specializes in the development of microbial therapeutics targeting diseases where the human microbiome holds curative potential. The company's platforms focus on secondary hyperoxaluria and explore treatments for metabolic disorders, immune diseases, and cancer. Federation Bio's approach involves leveraging naturally occurring or engineered bacteria alongside a diverse community of supportive bacteria to drive engraftment and durable therapeutic responses.
Carmot Therapeutics
Series C in 2020
Carmot Therapeutics, Inc. is a clinical-stage biotechnology company based in Berkeley, California, with an additional office in San Francisco. Founded in 2008, it focuses on discovering and developing innovative therapies for patients with metabolic diseases, including obesity and diabetes. Utilizing its proprietary Chemotype Evolution technology, Carmot Therapeutics aims to address the underlying causes of these conditions and accelerate the discovery of effective treatments. The company’s portfolio includes several clinical-stage drug candidates, such as CT-388 and CT-996, which are designed as GLP-1 receptor agonists for the treatment of obesity and type 2 diabetes, and CT-868, intended for type 1 diabetes patients who are overweight or obese. Through these efforts, Carmot Therapeutics seeks to create life-changing therapeutics that improve the health outcomes of individuals affected by metabolic diseases.
Brightseed
Venture Round in 2020
Brightseed, Inc. is a pioneering biosciences company based in San Francisco, California, founded in 2017. It specializes in the discovery of bioactive compounds in plants that have beneficial effects on human health, particularly for chronic disease management. Utilizing its proprietary Forager platform, which incorporates artificial intelligence and machine learning, Brightseed accelerates the identification and validation of these naturally occurring compounds, transforming what was once a lengthy process into a matter of months. By mapping bioactives to specific health outcomes, Brightseed provides valuable insights and science-backed solutions to partners across the consumer health continuum. The company's innovative approach aims to illuminate the connections between nature and human health, ultimately improving quality of life and addressing health challenges through the exploration of previously uncharted plant compounds.
Curio is a platform that allows individuals to stay informed by listening to hand-picked human-narrated news and articles from reliable publications, plus original shows and podcasts. Curio allows users to listen to the best articles from The Atlantic, The Wall Street Journal, The Financial Times, WIRED, The Economist, The Washington Post, Bloomberg, Aeon, and many other publications.
Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.
Atomo Coffee
Seed Round in 2020
Atomo Coffee Inc, founded in 2019 and based in Seattle, Washington, specializes in the development of molecular coffee. The company has innovatively reverse-engineered the coffee bean to produce a smooth cup of coffee using naturally derived ingredients. This approach aims to offer a more sustainable alternative to traditional coffee production methods, addressing environmental concerns associated with coffee cultivation. By focusing on sustainability and quality, Atomo Coffee is positioned to disrupt the conventional coffee market with its unique product offerings.
Docket, Inc. is a company that offers an online platform specifically designed for creating meeting agendas. Founded in 2018 and headquartered in Indianapolis, Indiana, Docket provides a workspace that facilitates collaborative agenda development, documentation of decisions, and tracking of action items. This platform aims to enhance the efficiency and organization of meetings, ensuring that users can effectively manage their discussions and follow-ups.
Perfect Day
Series C in 2020
Perfect Day, Inc. is a pioneering company based in Emeryville, California, that specializes in producing animal-free dairy products. Founded in 2014, the company creates milk, cheese, yogurt, milk proteins, and ice cream that are nutritionally identical to traditional dairy but are made through a fermentation process using plant-based sugars. This innovative approach allows Perfect Day to deliver products that retain the taste, texture, and nutrition of conventional dairy while eliminating concerns related to food safety, environmental impact, and animal welfare. The company's commitment to sustainability and compassion results in nutrient-dense alternatives that are vegan, free from antibiotics, cholesterol, and lactose, catering to a growing market for healthier and more ethical food options.
Ansa Biotechnologies
Seed Round in 2020
Ansa Biotechnologies, Inc. is a biotechnology company based in Berkeley, California, focused on developing innovative DNA synthesis technology utilizing enzymes. Founded in 2018, the company aims to transform the traditional methods of DNA production, which have remained largely unchanged for decades. Ansa's enzymatic approach promises to be faster, more accurate, and environmentally friendly compared to conventional chemical methods. This advanced technology facilitates the synthesis of gene-length oligonucleotides, enabling medical researchers to create synthetic genes efficiently. Ansa Biotechnologies' offerings are designed to support a wide range of applications in biological research, diagnostics, therapeutics, and biomanufacturing, ultimately accelerating innovation in the field of biotechnology.
Loam Bio
Seed Round in 2020
Loam Bio is a company focused on manufacturing microbial products designed to reduce atmospheric CO2 levels and enhance soil fertility. Founded in 2016 and based in Orange, Australia, the company is engaged in developing innovative technology that enables the inoculation of crops with symbiotic micro-organisms. This approach aims to improve agricultural sustainability by promoting healthier soils and more efficient carbon management.
Surrozen, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, focused on developing targeted regenerative antibodies to enhance tissue and organ repair in response to serious diseases. Founded in 2015, the company specializes in modulating the Wnt pathway, a crucial mediator of tissue regeneration, through its innovative antibody platforms that target specific organs and tissues. Notable programs include SZN-043, designed to stimulate liver regeneration in both acute and chronic liver diseases, and SZN-1326, aimed at repairing damaged epithelial tissue in patients with inflammatory bowel disease. Surrozen's approach extends to multiple organ systems, with potential applications in the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.